Estados Unidos · Plataformas y datos · MarketBeat

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00

Publicado por MarketBeat · Estados Unidos hace 1 h

Wells Fargo & Company lifted their target price on Vertex Pharmaceuticals from $550.00 to $650.00 and gave the company an "overweight" rating in a research note on Tuesday.

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00

También te puede interesar

Renew outlines FY2027 adjusted EBITDA guidance of INR 105B to INR 109B as take-private process targets Q1 2027 close

Want to help your adult kids and grandkids? Give them money while you’re still alive.

Where Will QuantumScape Stock Be in 5 Years?

Regal Rexnord Q3 2026 slides: organic growth accelerates to 6.1%

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00

Compartir

También te puede interesar

Renew outlines FY2027 adjusted EBITDA guidance of INR 105B to INR 109B as take-private process targets Q1 2027 close

Want to help your adult kids and grandkids? Give them money while you’re still alive.

Where Will QuantumScape Stock Be in 5 Years?

Regal Rexnord Q3 2026 slides: organic growth accelerates to 6.1%

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030